Mark Kay
MD, PhD
Dennis Farrey Family Professor in Pediatrics and Genetics; Director, Program in Human Gene Therapy
👥Biography 个人简介
Mark Kay is a gene therapy pioneer whose laboratory has developed AAV and RNAi strategies for liver-directed therapy including hepatocellular carcinoma. His work has advanced the field of in vivo RNA silencing in cancer. He directs the Program in Human Gene Therapy at Stanford.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Mark Kay 的研究动态
Follow Mark Kay's research updates
留下邮箱，当我们发布与 Mark Kay（Stanford University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment